Liraglutide Inhibits Hepatitis C Virus Replication Through an AMP Activated Protein Kinase Dependent Mechanism

Insulin resistance and diabetes are both associated with chronic hepatitis C virus (HCV) infection, and the glucagon-like peptide-1(GLP-1) receptor agonist, liraglutide, is a common therapy for diabetes. Our aim was to investigate whether liraglutide treatment can inhibit HCV replication. A cell cul...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Mei-Yueh, Chen, Wei-Chun, Hsu, Wei-Hao, Chen, Szu-Chia, Lee, Jin-Ching
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769880/
https://www.ncbi.nlm.nih.gov/pubmed/31540136
http://dx.doi.org/10.3390/ijms20184569

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769880/
https://www.ncbi.nlm.nih.gov/pubmed/31540136
http://dx.doi.org/10.3390/ijms20184569

Ejemplares similares